US Stock MarketDetailed Quotes

WVE Wave Life Sciences

Watchlist
  • 12.900
  • -0.580-4.30%
Close Dec 27 16:00 ET
  • 12.950
  • +0.050+0.39%
Post 20:01 ET
1.97BMarket Cap-11.52P/E (TTM)

Wave Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-34.89%-46.48M
26.27%-27.47M
-139.09%-33.43M
84.79%-19.43M
0.60%-33.24M
-34.36%-34.46M
-29.27%-37.26M
314.49%85.52M
-43.59%-127.78M
-375.47%-33.44M
Net income from continuing operations
-951.90%-61.78M
-56.00%-32.92M
-15.15%-31.56M
64.46%-57.51M
62.81%-16.26M
118.59%7.25M
48.90%-21.1M
27.53%-27.41M
-32.38%-161.82M
-25.65%-43.71M
Operating gains losses
----
----
----
----
----
----
----
----
--12K
----
Depreciation and amortization
-4.68%2.16M
-6.46%2.17M
-10.71%2.18M
-8.98%9.21M
-12.55%2.18M
-12.96%2.26M
-7.27%2.32M
-3.02%2.44M
2.84%10.11M
-1.69%2.5M
Change In working capital
120.78%9.61M
99.03%-202K
-106.43%-6.93M
183.86%19.08M
-543.19%-21.52M
-725.86%-46.26M
-791.52%-20.88M
1,360.99%107.74M
-4.11%6.72M
-77.41%4.86M
-Change in receivables
118.43%1.29M
---1.29M
--21.09M
---21.09M
---14.09M
---7M
--0
--0
--0
--0
-Change in prepaid assets
5.14%1.58M
-560.27%-1.01M
5.54%-1.23M
-46.88%-1.98M
-367.45%-2.4M
174.05%1.5M
-85.82%219K
-264.89%-1.3M
-135.01%-1.35M
-149.19%-513K
-Change in payables and accrued expense
-159.79%-1.61M
235.97%10.16M
22.80%-11.28M
-137.25%-4.49M
-41.44%4.4M
-46.51%2.7M
-38.64%3.03M
-168.36%-14.6M
427.41%12.04M
129.92%7.51M
-Change in other current assets
778.31%2.39M
98.95%-6K
22.73%-1.39M
-159.22%-2.01M
183.49%91K
-95.01%272K
48.04%-569K
-111.99%-1.8M
1,104.14%3.39M
92.13%-109K
-Change in other current liabilities
-1.31%-1.71M
-14.26%-1.66M
-58.08%-1.58M
-38.08%-5.69M
-95.83%-1.55M
-81.36%-1.68M
30.46%-1.45M
-222.19%-1M
5.57%-4.12M
63.55%-791K
-Change in other working capital
118.26%7.68M
71.04%-6.4M
-109.92%-12.54M
1,774.21%54.33M
-543.34%-7.97M
-27,742.38%-42.04M
-8,057.56%-22.11M
8,082.83%126.45M
82.43%-3.25M
29.80%-1.24M
Cash from discontinued investing activities
Operating cash flow
-34.89%-46.48M
26.27%-27.47M
-139.09%-33.43M
84.79%-19.43M
0.60%-33.24M
-34.36%-34.46M
-29.27%-37.26M
314.49%85.52M
-43.59%-127.78M
-375.47%-33.44M
Investing cash flow
Cash flow from continuing investing activities
-93.43%-383K
27.78%-52K
14.72%-417K
11.16%-1.12M
-101.43%-356K
60.48%-198K
-100.29%-72K
99.03%-489K
-124.11%-1.26M
165,700.00%24.84M
Net PPE purchase and sale
-93.43%-383K
27.78%-52K
14.72%-417K
11.16%-1.12M
-74.51%-356K
56.67%-198K
81.35%-72K
-135.10%-489K
-124.11%-1.26M
-1,260.00%-204K
Net investment purchase and sale
----
----
----
--0
----
----
----
----
--0
--25.04M
Cash from discontinued investing activities
Investing cash flow
-93.43%-383K
27.78%-52K
14.72%-417K
11.16%-1.12M
-101.43%-356K
60.48%-198K
-100.29%-72K
99.03%-489K
-124.11%-1.26M
165,700.00%24.84M
Financing cash flow
Cash flow from continuing financing activities
12,100.36%203.75M
-64.68%653K
-58.61%14.51M
97.26%132.53M
170,740.00%93.96M
9,723.53%1.67M
-97.19%1.85M
2,563.60%35.05M
20.35%67.19M
-99.84%55K
Net common stock issuance
14,234.80%188.65M
-68.99%547K
-59.45%14.04M
150.89%131.28M
121,624.68%93.57M
888.02%1.32M
-96.57%1.76M
3,033.30%34.62M
-4.81%52.33M
-100.23%-77K
Proceeds from stock option exercised by employees
4,165.54%15.1M
24.71%106K
9.77%472K
-91.54%1.26M
193.94%388K
92.39%354K
-99.41%85K
103.79%430K
1,632.28%14.86M
--132K
Cash from discontinued financing activities
Financing cash flow
12,100.36%203.75M
-64.68%653K
-58.61%14.51M
97.26%132.53M
170,740.00%93.96M
9,723.53%1.67M
-97.19%1.85M
2,563.60%35.05M
20.35%67.19M
-99.84%55K
Net cash flow
Beginning cash position
-10.73%157.69M
-13.00%184.64M
121.42%204.05M
-40.24%92.16M
42.76%143.63M
39.29%176.64M
224.68%212.22M
-40.24%92.16M
-18.04%154.22M
-21.12%100.61M
Current changes in cash
575.63%156.89M
24.28%-26.87M
-116.10%-19.34M
281.07%111.99M
806.46%60.37M
-26.23%-32.99M
-157.60%-35.48M
235.29%120.09M
-83.39%-61.85M
-131.95%-8.55M
Effect of exchange rate changes
475.00%120K
19.00%-81K
-252.38%-74K
54.76%-95K
-38.30%58K
57.89%-32K
29.58%-100K
75.58%-21K
-0.96%-210K
222.08%94K
End cash Position
119.11%314.69M
-10.73%157.69M
-13.00%184.64M
121.42%204.05M
121.42%204.05M
42.76%143.63M
39.29%176.64M
224.68%212.22M
-40.24%92.16M
-40.24%92.16M
Free cash flow
-35.22%-46.86M
26.28%-27.52M
-139.81%-33.85M
84.09%-20.55M
0.15%-33.6M
-32.76%-34.66M
-27.34%-37.33M
312.15%85.03M
-44.21%-129.14M
-377.36%-33.64M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -34.89%-46.48M26.27%-27.47M-139.09%-33.43M84.79%-19.43M0.60%-33.24M-34.36%-34.46M-29.27%-37.26M314.49%85.52M-43.59%-127.78M-375.47%-33.44M
Net income from continuing operations -951.90%-61.78M-56.00%-32.92M-15.15%-31.56M64.46%-57.51M62.81%-16.26M118.59%7.25M48.90%-21.1M27.53%-27.41M-32.38%-161.82M-25.65%-43.71M
Operating gains losses ----------------------------------12K----
Depreciation and amortization -4.68%2.16M-6.46%2.17M-10.71%2.18M-8.98%9.21M-12.55%2.18M-12.96%2.26M-7.27%2.32M-3.02%2.44M2.84%10.11M-1.69%2.5M
Change In working capital 120.78%9.61M99.03%-202K-106.43%-6.93M183.86%19.08M-543.19%-21.52M-725.86%-46.26M-791.52%-20.88M1,360.99%107.74M-4.11%6.72M-77.41%4.86M
-Change in receivables 118.43%1.29M---1.29M--21.09M---21.09M---14.09M---7M--0--0--0--0
-Change in prepaid assets 5.14%1.58M-560.27%-1.01M5.54%-1.23M-46.88%-1.98M-367.45%-2.4M174.05%1.5M-85.82%219K-264.89%-1.3M-135.01%-1.35M-149.19%-513K
-Change in payables and accrued expense -159.79%-1.61M235.97%10.16M22.80%-11.28M-137.25%-4.49M-41.44%4.4M-46.51%2.7M-38.64%3.03M-168.36%-14.6M427.41%12.04M129.92%7.51M
-Change in other current assets 778.31%2.39M98.95%-6K22.73%-1.39M-159.22%-2.01M183.49%91K-95.01%272K48.04%-569K-111.99%-1.8M1,104.14%3.39M92.13%-109K
-Change in other current liabilities -1.31%-1.71M-14.26%-1.66M-58.08%-1.58M-38.08%-5.69M-95.83%-1.55M-81.36%-1.68M30.46%-1.45M-222.19%-1M5.57%-4.12M63.55%-791K
-Change in other working capital 118.26%7.68M71.04%-6.4M-109.92%-12.54M1,774.21%54.33M-543.34%-7.97M-27,742.38%-42.04M-8,057.56%-22.11M8,082.83%126.45M82.43%-3.25M29.80%-1.24M
Cash from discontinued investing activities
Operating cash flow -34.89%-46.48M26.27%-27.47M-139.09%-33.43M84.79%-19.43M0.60%-33.24M-34.36%-34.46M-29.27%-37.26M314.49%85.52M-43.59%-127.78M-375.47%-33.44M
Investing cash flow
Cash flow from continuing investing activities -93.43%-383K27.78%-52K14.72%-417K11.16%-1.12M-101.43%-356K60.48%-198K-100.29%-72K99.03%-489K-124.11%-1.26M165,700.00%24.84M
Net PPE purchase and sale -93.43%-383K27.78%-52K14.72%-417K11.16%-1.12M-74.51%-356K56.67%-198K81.35%-72K-135.10%-489K-124.11%-1.26M-1,260.00%-204K
Net investment purchase and sale --------------0------------------0--25.04M
Cash from discontinued investing activities
Investing cash flow -93.43%-383K27.78%-52K14.72%-417K11.16%-1.12M-101.43%-356K60.48%-198K-100.29%-72K99.03%-489K-124.11%-1.26M165,700.00%24.84M
Financing cash flow
Cash flow from continuing financing activities 12,100.36%203.75M-64.68%653K-58.61%14.51M97.26%132.53M170,740.00%93.96M9,723.53%1.67M-97.19%1.85M2,563.60%35.05M20.35%67.19M-99.84%55K
Net common stock issuance 14,234.80%188.65M-68.99%547K-59.45%14.04M150.89%131.28M121,624.68%93.57M888.02%1.32M-96.57%1.76M3,033.30%34.62M-4.81%52.33M-100.23%-77K
Proceeds from stock option exercised by employees 4,165.54%15.1M24.71%106K9.77%472K-91.54%1.26M193.94%388K92.39%354K-99.41%85K103.79%430K1,632.28%14.86M--132K
Cash from discontinued financing activities
Financing cash flow 12,100.36%203.75M-64.68%653K-58.61%14.51M97.26%132.53M170,740.00%93.96M9,723.53%1.67M-97.19%1.85M2,563.60%35.05M20.35%67.19M-99.84%55K
Net cash flow
Beginning cash position -10.73%157.69M-13.00%184.64M121.42%204.05M-40.24%92.16M42.76%143.63M39.29%176.64M224.68%212.22M-40.24%92.16M-18.04%154.22M-21.12%100.61M
Current changes in cash 575.63%156.89M24.28%-26.87M-116.10%-19.34M281.07%111.99M806.46%60.37M-26.23%-32.99M-157.60%-35.48M235.29%120.09M-83.39%-61.85M-131.95%-8.55M
Effect of exchange rate changes 475.00%120K19.00%-81K-252.38%-74K54.76%-95K-38.30%58K57.89%-32K29.58%-100K75.58%-21K-0.96%-210K222.08%94K
End cash Position 119.11%314.69M-10.73%157.69M-13.00%184.64M121.42%204.05M121.42%204.05M42.76%143.63M39.29%176.64M224.68%212.22M-40.24%92.16M-40.24%92.16M
Free cash flow -35.22%-46.86M26.28%-27.52M-139.81%-33.85M84.09%-20.55M0.15%-33.6M-32.76%-34.66M-27.34%-37.33M312.15%85.03M-44.21%-129.14M-377.36%-33.64M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+0.58%
Halozyme Therapeutics
HALO
+0.21%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%
YETI Holdings
YETI
-0.08%
Dorian LPG
LPG
-0.25%

Unlock the Full List